State of Alaska, Department of Revenue - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
State of Alaska, Department of Revenue ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$344
-27.1%
12,837
-3.1%
0.00%
-33.3%
Q2 2023$472
+24.5%
13,252
-11.2%
0.01%
+50.0%
Q1 2023$379
-36.3%
14,923
+1.6%
0.00%
-42.9%
Q4 2022$595
-99.9%
14,6880.0%0.01%0.0%
Q3 2022$485,000
-9.2%
14,688
-3.2%
0.01%0.0%
Q2 2022$534,000
-21.7%
15,173
+2.2%
0.01%0.0%
Q1 2022$682,000
-31.8%
14,843
-1.7%
0.01%
-30.0%
Q4 2021$1,000,000
+0.1%
15,093
-5.7%
0.01%0.0%
Q3 2021$999,000
-25.4%
16,003
-1.0%
0.01%
-28.6%
Q2 2021$1,339,000
+24.2%
16,172
-0.6%
0.01%
+16.7%
Q1 2021$1,078,000
-15.8%
16,262
-2.6%
0.01%
-20.0%
Q4 2020$1,280,000
+70.4%
16,694
-4.4%
0.02%
+66.7%
Q3 2020$751,000
-3.8%
17,457
-3.5%
0.01%
-10.0%
Q2 2020$781,000
+57.5%
18,097
+4.9%
0.01%
+25.0%
Q1 2020$496,000
-52.4%
17,251
+4.8%
0.01%
-42.9%
Q4 2019$1,043,000
-49.4%
16,455
-77.5%
0.01%
-50.0%
Q3 2019$2,063,000
+141.3%
73,212
+126.9%
0.03%
+100.0%
Q2 2019$855,00032,2650.01%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,264$54,392,00033.22%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$216,228,00028.00%
L1 Capital Pty Ltd 296,024$19,629,0004.93%
Aquilo Capital Management, LLC 407,926$27,050,0004.89%
Evolutionary Tree Capital Management, LLC 72,948$4,837,0002.86%
ACUTA CAPITAL PARTNERS, LLC 108,000$7,161,0002.58%
First Light Asset Management, LLC 536,836$35,598,0002.36%
Parkman Healthcare Partners LLC 70,089$4,648,0001.08%
Hood River Capital Management LLC 357,082$23,678,0000.76%
Vanguard Capital Wealth Advisors 11,099$703,565,0000.60%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders